75-kd sirtuin 1 blocks tumor necrosis factor α-mediated apoptosis in human osteoarthritic chondrocytes

Arthritis and Rheumatism

Volumn 64, Issue 3, 2012, Pages 718-728

  Oppenheimer, Hanna ^a   Gabay, Odile ^b   Meir, Hadar ^a   Haze, Amir ^c   Kandel, Leonid ^c   Liebergall, Meir ^c   Gagarina, Viktoria ^b   Lee, Eun Jin ^b   Dvir Ginzberg, Mona ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 8; CATHEPSIN B; CYTOCHROME C OXIDASE; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MITOCHONDRIAL ENZYME; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; SB202190; SIRTUIN 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AGED; APOPTOSIS; ARTICLE; CARTILAGE CELL; CELL MIGRATION; CELL SURVIVAL; CONTROLLED STUDY; DATA ANALYSIS; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHESIS; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; MEDICAL RECORD; OSTEOARTHRITIS; PRIORITY JOURNAL; STIMULATION; SYNOVIAL FLUID;

AGED; APOPTOSIS; CARTILAGE, ARTICULAR; CATHEPSIN B; CELL SURVIVAL; CELLS, CULTURED; CHONDROCYTES; CYTOCHROMES C; CYTOPLASM; GENE EXPRESSION; HUMANS; MITOCHONDRIA; OSTEOARTHRITIS, KNEE; SIRTUIN 1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84857752986     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.33407     Document Type: Article

References (51)

1. Iannone F, Lapadula G,. The pathophysiology of osteoarthritis. Aging Clin Exp Res 2003; 15: 364-72.
2. Goldring SR, Goldring MB,. Clinical aspects, pathology and pathophysiology of osteoarthritis. J Musculoskelet Neuronal Interact 2006; 6: 376-8.
3. Petersson IF, Jacobsson LT,. Osteoarthritis of the peripheral joints. Best Pract Res Clin Rheumatol 2002; 16: 741-60.
4. Loeser RF,. Age-related changes in the musculoskeletal system and the development of osteoarthritis. Clin Geriatr Med 2010; 26: 371-86.
5. Fernandes JC, Martel-Pelletier J, Pelletier JP,. The role of cytokines in osteoarthritis pathophysiology. Biorheology 2002; 39: 237-46.
6. Furuzawa-Carballeda J, Macip-Rodriguez PM, Cabral AR,. Osteoarthritis and rheumatoid arthritis pannus have similar qualitative metabolic characteristics and pro-inflammatory cytokine response. Clin Exp Rheumatol 2008; 26: 554-60.
7. Burrage PS, Mix KS, Brinckerhoff CE,. Matrix metalloproteinases: role in arthritis. Front Biosci 2006; 11: 529-43.
8. Dvir-Ginzberg M, Gagarina V, Lee EJ, Hall DJ,. Regulation of cartilage-specific gene expression in human chondrocytes by SirT1 and nicotinamide phosphoribosyltransferase. J Biol Chem 2008; 283: 36300-10.
9. Fujita N, Matsushita T, Ishida K, Kubo S, Matsumoto T, Takayama K, et al. Potential involvement of SIRT1 in the pathogenesis of osteoarthritis through the modulation of chondrocyte gene expressions. J Orthop Res 2011; 29: 511-5.
10. Dvir-Ginzberg M, Gagarina V, Lee EJ, Booth R, Gabay O, Hall DJ,. Tumor necrosis factor α-mediated cleavage and inactivation of SirT1 in human osteoarthritic chondrocytes. Arthritis Rheum 2011; 63: 2363-73.
11. Baici A, Horler D, Lang A, Merlin C, Kissling R,. Cathepsin B in osteoarthritis: zonal variation of enzyme activity in human femoral head cartilage. Ann Rheum Dis 1995; 54: 281-8.
12. Baici A, Lang A, Horler D, Kissling R, Merlin C,. Cathepsin B in osteoarthritis: cytochemical and histochemical analysis of human femoral head cartilage. Ann Rheum Dis 1995; 54: 289-97.
13. Sasaki T, Maier B, Koclega KD, Chruszcz M, Gluba W, Stukenberg PT, et al. Phosphorylation regulates SIRT1 function. PLoS One 2008; 3: e4020.
14. Yang Y, Fu W, Chen J, Olashaw N, Zhang X, Nicosia SV, et al. SIRT1 sumoylation regulates its deacetylase activity and cellular response to genotoxic stress [published erratum appears in Nat Cell Biol 2007;9:1442]. Nat Cell Biol 2007; 9: 1253-62.
15. Blanco FJ, Guitian, R, Vazquez-Martul E, de Toro FJ, Galdo F,. Osteoarthritis chondrocytes die by apoptosis: a possible pathway for osteoarthritis pathology. Arthritis Rheum 1998; 41: 284-9.
16. Yatsugi N, Tsukazaki T, Osaki M, Koji T, Tamashita S, Shindo H,. Apoptosis of articular chondrocytes in rheumatoid arthritis and osteoarthritis: correlation of apoptosis with degree of cartilage destruction and expression of apoptosis-related proteins of p53 and c-myc. J Orthop Sci 2000; 5: 150-6.
17. Takayama K, Ishida K, Matsushita T, Fujita N, Hayashi S, Sasaki K, et al. SIRT1 regulation of apoptosis of human chondrocytes. Arthritis Rheum 2009; 60: 2731-40.
18. Gagarina V, Gabay O, Dvir-Ginzberg M, Lee EJ, Brady JK, Quon MJ, et al. SirT1 enhances survival of human osteoarthritic chondrocytes by repressing protein tyrosine phosphatase 1B and activating the insulin-like growth factor receptor pathway. Arthritis Rheum 2010; 62: 1383-92.
19. Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, et al. Modulation of NF-κB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 2004; 23: 2369-80.
20. SIRT1 functions as an NAD-dependent p53 deacetylase. Cell 2001; 107: 149-59.
21. Derfoul A, Miyoshi AD, Freeman DE, Tuan RS,. Glucosamine promotes chondrogenic phenotype in both chondrocytes and mesenchymal stem cells and inhibits MMP-13 expression and matrix degradation. Osteoarthritis Cartilage 2007; 15: 646-55.
22. Perkins GL, Derfoul A, Ast A, Hall DJ,. An inhibitor of the stretch-activated cation receptor exerts a potent effect on chondrocyte phenotype. Differentiation 2005; 73: 199-211.
23. Davidson RK, Waters JG, Kevorkian L, Darrah C, Cooper A, Donell ST, et al. Expression profiling of metalloproteinases and their inhibitors in synovium and cartilage. Arthritis Res Ther 2006; 8: R124.
24. Goldring MB,. Osteoarthritis and cartilage: the role of cytokines. Curr Rheumatol Rep 2000; 2: 459-65.
25. Manicourt DH, Poilvache P, van Egeren A, Devogelaer JP, Lenz ME, Thonar EJ,. Synovial fluid levels of tumor necrosis factor α and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis. Arthritis Rheum 2000; 43: 281-8.
26. Guicciardi EM, Deussing J, Miyoshi H, Bronk SF, Svingen PA, Peters C, et al. Cathepsin B contributes to TNF-α-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J Clin Invest 2000; 106: 1127-37.
27. Leist M, Jaattela M,. Triggering of apoptosis by cathepsins. Cell Death Differ 2001; 8: 324-6.
28. Li JH, Pober JS,. The cathepsin B death pathway contributes to TNF plus IFN-γ-mediated human endothelial injury. J Immunol 2005; 175: 1858-66.
29. Werneburg NW, Guicciardi ME, Bronk SF, Gores GJ,. Tumor necrosis factor-α-associated lysosomal permeabilization is cathepsin B dependent. Am J Physiol Gastrointest Liver Physiol 2002; 283: G947-56.
30. Jin Q, Yan T, Ge X, Sun C, Shi X, Zhai Q,. Cytoplasm-localized SIRT1 enhances apoptosis. J Cell Physiol 2007; 213: 88-97.
31. +-dependent histone deacetylase SIRT1. J Biol Chem 2007; 282: 6823-32.
32. Russo M, Mupo A, Spagnuolo C, Russo GL,. Exploring death receptor pathways as selective targets in cancer therapy. Biochem Pharmacol 2010; 80: 674-82.
33. Hallows WC, Lee S, Denu JM,. Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases. Proc Natl Acad Sci U S A 2006; 103: 10230-5.
34. Chiche J, Rouleau M, Gounon P, Brahimi-Horn MC, Pouyssegur J, Mazure NM,. Hypoxic enlarged mitochondria protect cancer cells from apoptotic stimuli. J Cell Physiol 2010; 222: 648-57.
35. Yoon YS, Yoon DS, Lim IK, Yoon SH, Chung HY, Rojo M, et al. Formation of elongated giant mitochondria in DFO-induced cellular senescence: involvement of enhanced fusion process through modulation of Fis1. J Cell Physiol 2006; 209: 468-80.
36. Berliner JA,. Formation of enlarged mitochondria in a liver cell line in response to a synthetic glucocorticoid. J Cell Biol 1975; 64: 711-6.
37. Vickers AE, Bentley P, Fisher RL,. Consequences of mitochondrial injury induced by pharmaceutical fatty acid oxidation inhibitors is characterized in human and rat liver slices. Toxicol In Vitro 2006; 20: 1173-82.
38. Buki A, Okonkwo DO, Wang KK, Povlishock JT,. Cytochrome c release and caspase activation in traumatic axonal injury. J Neurosci 2000; 20: 2825-34.
39. Cirman T, Oresic K, Mazovec GD, Turk V, Reed JC, Myers RM, et al. Selective disruption of lysosomes in HeLa cells triggers apoptosis mediated by cleavage of Bid by multiple papain-like lysosomal cathepsins. J Biol Chem 2004; 279: 3578-87.
40. Lee JH, Song MY, Song EK, Kim EK, Moon WS, Han MK, et al. Overexpression of SIRT1 protects pancreatic β-cells against cytokine toxicity by suppressing the nuclear factor-κB signaling pathway. Diabetes 2009; 58: 344-51.
41. Zhang HN, Li L, Gao P, Chen HZ, Zhang R, Wei YS, et al. Involvement of the p65/RelA subunit of NF-κB in TNF-α-induced SIRT1 expression in vascular smooth muscle cells. Biochem Biophys Res Commun 2010; 397: 569-75.
42. Singh UP, Singh NP, Singh B, Hofseth LJ, Price RL, Hagarkatti M, et al. Resveratrol (trans-3,5,4′-trihydroxystilbene) induces silent mating type information regulation-1 and down-regulates nuclear transcription factor-κB activation to abrogate dextran sulfate sodium-induced colitis. J Pharmacol Exp Ther 2010; 332: 829-39.
43. Stein S, Matter CM,. Protective roles of SIRT1 in atherosclerosis. Cell Cycle 2011; 10: 640-7.
44. Ivanova IA, Dagnino L,. Activation of p38- and CRM1-dependent nuclear export promotes E2F1 degradation during keratinocyte differentiation. Oncogene 2007; 26: 1147-54.
45. Beer HM,. Death versus survival: functional interaction between the apoptotic and stress-inducible heat shock protein pathways. J Clin Invest 2005; 115: 2633-9.
46. Hou J, Chong ZZ, Shang YC, Maiese K,. Early apoptotic vascular signaling is determined by Sirt1 through nuclear shuttling, forkhead trafficking, bad, and mitochondrial caspase activation. Curr Neurovasc Res 2010; 7: 95-112.
47. Duncan EM, Allis CD,. Errors in erasure: links between histone lysine methylation removal and disease. Prog Drug Res 2011; 67: 69-90.
48. Duncan EM, Muratore-Schroeder TL, Cook RG, Garcia BA, Shabanowitz J, Hunt DF, et al. Cathepsin L proteolytically processes histone H3 during mouse embryonic stem cell differentiation. Cell 2008; 135: 284-94
49. Turk B, Turk V, Turk D,. Structural and functional aspects of papain-like cysteine proteinases and their protein inhibitors. Biol Chem 1997; 378: 141-50.
50. Hazen LG, Bleeker FE, Lauritzen B, Bahns S, Song J, Jonker A, et al. Comparative localization of cathepsin B protein and activity in colorectal cancer. J Histochem Cytochem 2000; 48: 1421-30.
51. Spiess E, Bruning A, Gack S, Ulbricht B, Spring H, Trefz G, et al. Cathepsin B activity in human lung tumor cell lines: ultrastructural localization, pH sensitivity, and inhibitor status at the cellular level. J Histochem Cytochem 1994; 42: 917-29.